Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate …
G Li, H Zhang, W Zhou, Q Ye, F Li, H Wang, Q Hou… - Vaccine, 2010 - Elsevier
To evaluate the safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and
Haemophilus infuenzae Type b (DTaP/Hib) combination vaccine first developed by a …
Haemophilus infuenzae Type b (DTaP/Hib) combination vaccine first developed by a …
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
C Sirivichayakul, P Chanthavanich… - Human vaccines & …, 2017 - Taylor & Francis
ABSTRACT Background: An acellular Pertussis (aP) vaccine containing recombinant
genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and …
genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and …
Safety and immunogenicity of combined diphtheria–tetanus–pertussis (whole cell and acellular)–Haemophilus influenzae-b conjugate vaccines administered to …
E Richie, NH Punjabi, SJ Harjanto, F Wangsasaputral… - Vaccine, 1999 - Elsevier
A randomized, double-blind trial was conducted to evaluate the safety and immunogenicity
of vaccines comprised of diphtheria (D) and tetanus (T) toxoids combined with either a …
of vaccines comprised of diphtheria (D) and tetanus (T) toxoids combined with either a …
[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
A Tomovici, L Barreto, P Zickler, W Meekison, F Noya… - Vaccine, 2012 - Elsevier
Persistence of antibodies after a single dose of Tdap vaccine (tetanus, diphtheria, and 5-
component acellular pertussis vaccine) was evaluated in a follow-up study of adolescents …
component acellular pertussis vaccine) was evaluated in a follow-up study of adolescents …
Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17− to 24-month-old children
M Glode, L Joffe, K Reisinger, M Blatter… - The Pediatric …, 1992 - journals.lww.com
A double-blind, randomized, controlled trial comparing 4 lots of acellular pertussis-
diphtheria tetanus toxoids vaccine (APDT) to whole cell DTP vaccine in 397 children was …
diphtheria tetanus toxoids vaccine (APDT) to whole cell DTP vaccine in 397 children was …
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …
M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …
increasing number of outbreaks have been observed over the last decades. The reduced …
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight …
HJ Schmitt, K Beutel, A Schuind, M Knuf… - The Journal of …, 1997 - Elsevier
Objectives: The primary objective was to assess the nature and incidence of adverse events
after a fourth dose of a tricomponent acellular pertussis-diphtheria-tetanus vaccine given in …
after a fourth dose of a tricomponent acellular pertussis-diphtheria-tetanus vaccine given in …
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus …
RC Li, FX Li, YP Li, QM Hou, CG Li, YN Li, FS Chen… - Vaccine, 2011 - Elsevier
The aim was to demonstrate the immunogenicity and safety of a DTaP-IPV//PRP-T combined
vaccine (Pentaxim®) compared to individual vaccines in infants in the People's Republic of …
vaccine (Pentaxim®) compared to individual vaccines in infants in the People's Republic of …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination …
E Mallet, N Matisse, N Mathieu, J Langue, F Boisnard… - Vaccine, 2004 - Elsevier
The main objective of this study was to assess in 5–6-year-old French children (n= 234) the
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …